Association between STAT4 gene polymorphism and susceptibility to pulmonary tuberculosis in the Moldavian population.
Alexander VarzariElena TudorAndrei CorloteanuEcaterina AxentiiIurie VladeiIgor V DeynekoPublished in: International journal of immunogenetics (2024)
Signal transducer and activator of transcription 4 (STAT4) plays a crucial role in the host immune response against Mycobacterium tuberculosis. This study investigates the association between STAT4 gene polymorphisms and pulmonary tuberculosis (TB) risk in the Moldavian population. A total of 272 TB patients and 251 community-matched controls underwent screening for functional single-nucleotide polymorphisms (SNPs) rs897200 and rs7574865 in the STAT4 gene. The minor T allele and the TT/CT genotype of rs897200 demonstrated a significant association with reduced pulmonary TB risk (allelic model: adjusted OR = .74, p = .025; log-additive model: adjusted OR = .72, p = .02; and dominant model: adjusted OR = .65, p = .023), indicating a protective effect. Similar associations, characterized by an even more pronounced reduction in risk, were observed among females and late-onset TB patients (>44 years). No significant associations were found for rs7574865. In addition, a combined genotype analysis incorporating 43 SNPs from our previous studies revealed potential associations, such as STAT4 rs897200 CT with IFNG rs2430561 AA (adjusted OR = .36, p = .0025) and STAT4 rs897200 CT with TNFA rs1800629 GA (adjusted OR = .33, p = .0012). This study emphasizes the significant association of STAT4 rs897200 with pulmonary TB risk in the Moldavian population, underscoring its role in the disease development.
Keyphrases
- mycobacterium tuberculosis
- pulmonary tuberculosis
- cell proliferation
- late onset
- end stage renal disease
- immune response
- computed tomography
- ejection fraction
- newly diagnosed
- chronic kidney disease
- pulmonary hypertension
- early onset
- mental health
- prognostic factors
- image quality
- dual energy
- gene expression
- contrast enhanced
- dna methylation
- patient reported
- transcription factor
- inflammatory response
- patient reported outcomes
- toll like receptor
- risk assessment
- human health